6,678 trials
Opioid Dependence
Primary: Overall Intervention Preference As Assessed by Participants — 54.84; 45.16 percentage of participants — p=>0.5000
Multiple Sclerosis
Primary: Change From Screening in Selective Reminding Test - Long-Term Storage (SRT-LTS) Raw Score — 6.32; 4.46 raw score — p=0.4940
Healthy
Primary: Change in Body Weight — 3.2; 0.8; 0.4 kg
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Participants Who Made at Least One Critical Error After Reading the Patient Information Leaflet — 2; 4; 1; 4 Percentage of participants — p=<0.001
Periodontal Disease
Primary: Relative Horizontal Clinical Attachment Level (RHCAL) at 12 Months — 2.31; 3.00; 2.57 mm
Acne Vulgaris
Primary: Adherence — 46.5 percentage of doses actually applied
Atopic Dermatitis
Primary: Adherence to Locoid — .55; .60; .50 percentage of days
Postoperative Pain
Primary: Patient Pain Scores — 33.6; 40.0; 34.9; 46.3 units on a scale- VAS
Carcinoma, Basal Cell · Carcinoma, Squamous Cell · Skin Neoplasms
Primary: The Time to Diagnosis of the First Keratinocyte Carcinoma (KC) on the Face or Ears for Which Surgery is Performed — 3.37; 3.52 years — p=0.93
Acellular Pertussis · Tetanus · Diphtheria
Primary: Number of Subjects With Anti-diphtheria (Anti-D) and Anti-tetanus (Anti-T) Antibodies — 427; 405; 425; 412 Participants
Glabellar Frown Lines
Primary: Efficacy, Measured as the Percentage of Participants Who Responded to Treatment — 95.7; 99.2 percentage of participants
Dentin Sensitivity
Primary: Change From Baseline in Schiff Sensitivity Score on Day 3 — -0.40; 0.00 Score on a scale — p=<0.0001
Occasional Sleeplessness
Primary: Mean Latency to Persistent Sleep — 19.1; 27.1 minutes — p=0.0312
Menopause
Primary: Menopause Quality Of Life Questionnaire (MENQOL) Physical Domain Subscale — 1.9 units on a scale
Bronchiolitis · Wheezing
Primary: Score Respiratory Distress — 8; 8; 6; 8 units on a scale